Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00325897 · ClinicalTrials.gov registry record · NA
Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With Chronic Obstructive Pulmonary Disease
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 1,142
- Enrollment target
NCT00325897 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 1,142 participants.
The verdict
NCT00325897, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,142 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if long-term administration of a macrolide antibiotic will reduce worsening of symptoms among individuals with chronic obstructive pulmonary disease (COPD).
Interventions
- DRUG Placebo
- DRUG Macrolide Antibiotic (Azithromycin)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,142 participants |
| Start Date | 2006-03 |
| Est. Completion | 2010-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00325897
The ClinicalTrials.gov registry entry for NCT00325897 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00325897 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00325897 about?
NCT00325897 is a clinical study titled "Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With Chronic Obstructive Pulmonary Disease". The purpose of this study is to determine if long-term administration of a macrolide antibiotic will reduce worsening of symptoms among individuals with chronic obstructive pulmonary disease (COPD).
What is the current status of trial NCT00325897?
This trial is currently completed. It is a NA study. The enrollment target is 1,142 participants. The study started on 2006-03. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00325897?
The interventions under investigation include: Placebo (DRUG), Macrolide Antibiotic (Azithromycin) (DRUG).
Who is sponsoring clinical trial NCT00325897?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.